Targeting plasma kallikrein with a novel bicyclic peptide inhibitor (THR-149) reduces retinal inflammation and reactive gliosis in a diabetic rat model

Van Bergen, Tine – Euretina – 9-12 September 2021

Publication date:
September, 2021